Detalles de la búsqueda
1.
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?
BMC Health Serv Res;
23(1): 484, 2023 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37179322
2.
Using IMPrESS to guide policy change in multiple sclerosis.
Mult Scler;
24(9): 1251-1255, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29064774
3.
DIFFERENTIATION OF HEALTH-RELATED QUALITY OF LIFE OUTCOMES BETWEEN FIVE DISEASE AREAS: RESULTS FROM AN INTERNATIONAL SURVEY OF PATIENTS.
Int J Technol Assess Health Care;
34(5): 498-506, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30251618
4.
Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented?
Int J Technol Assess Health Care;
30(1): 10-19, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24499622
5.
Commentary: Advocating for patient and public involvement and engagement in health economic evaluation.
Res Involv Engagem;
9(1): 45, 2023 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37400923
6.
Patients' perspectives in health technology assessment: a route to robust evidence and fair deliberation.
Int J Technol Assess Health Care;
26(3): 334-40, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20584364
7.
Health related quality of life aspects not captured by EQ-5D-5L: Results from an international survey of patients.
Health Policy;
123(2): 159-165, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30598239
Resultados
1 -
7
de 7
1
Próxima >
>>